Sorrento Therapeutics, Inc. Contracts & Agreements

220 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
CONTRIBUTION AGREEMENT by and among CELULARITY, INC., TNK THERAPEUTICS, INC. and SORRENTO THERAPEUTICS, INC. Dated: June 12, 2017
Contribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2017
Asset Purchase Agreement, dated October 30, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc
Purchase Agreements
Sorrento Therapeutics, Inc.
2023
Manufacturing Technology Transfer Agreement, dated November 2, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
2023
Stock Purchase Agreement, dated September 29, 2023, between Dr. Robert J. Hariri, M.D., Ph. D., and Sorrento Therapeutics, Inc
Stock Agreements
Sorrento Therapeutics, Inc.
2023
Stock Purchase Agreement, dated September 21, 2023, between Scilex Holding Company and Sorrento Therapeutics, Inc
Stock Agreements
Sorrento Therapeutics, Inc.
2023
Mutual Termination and Release Agreement, dated September 21, 2023, between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc
Termination Agreements
Sorrento Therapeutics, Inc.
2023
Assignment, Assumption and Release Agreement, dated September 21, 2023, between Scilex Holding Company, Oramed Pharmaceuticals, Inc., Sorrento Therapeutics, Inc. and Scintilla...
Release Agreements
Sorrento Therapeutics, Inc.
2023
Second Amendment to Stock Purchase Agreement, dated August 21, 2023, between Sorrento Therapeutics, Inc. amd Oramed Pharmaceuticals Inc
Stock Agreements
Sorrento Therapeutics, Inc.
2023
Stock Purchase Agreement, Dated August 7, 2023 between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals Inc
Stock Agreements
Sorrento Therapeutics, Inc.
2023
Amendment Agreement to Stock Purchase Agreement, Dated August 9, 2023, between Sorrento Therapeutics, Inc. amd Oramed Pharmaceutircals Inc
Stock Agreements
Sorrento Therapeutics, Inc.
2023
Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement, dated March 30, 2023, by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc.,...
Loan Agreements
Sorrento Therapeutics, Inc.
2023
Debtor-in-Possession Term Loan Facility Summary of Terms and Conditions, dated as of July 5, 2023, between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc. and Scilex...
Loan Agreements
Sorrento Therapeutics, Inc.
2023
Intercreditor and Subordination Agreement, dated as of July 5, 2023, by and among JMB Capital Partners Lending, LLC and Scilex Holding Company
Subordination Agreement
Sorrento Therapeutics, Inc.
2023
Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement, dated March 30, 2023, by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc.,...
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2023
Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Sorrento Therapeutics, Inc.
2022
Bridge Loan Agreement, dated as of September 30, 2022, by and between Sorrento Therapeutics, Inc. and B. Riley Commercial Capital, LLC
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 1 to Agreement and Plan of Merger, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company
Merger Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Contribution and Satisfaction of Indebtedness Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Scilex...
Contribution Agreements
Sorrento Therapeutics, Inc.
2022
Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I
Sorrento Therapeutics, Inc.
2022
Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on...
Sorrento Therapeutics, Inc.
Biotechnology
2022
Consent Under and Amendment No. 4 to Indenture, dated June 3, 2022, by and among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., U.S. Bank Trust Company, National...
Indenture Agreements
Sorrento Therapeutics, Inc.
2022
Offer Letter, dated April 27, 2022, between Sorrento Therapeutics, Inc. and Elizabeth A. Czerepak
Sorrento Therapeutics, Inc.
Biotechnology
2022
Offer Letter, dated April 27, 2022, between Scilex Holding Company and Elizabeth A. Czerepak
Sorrento Therapeutics, Inc.
2022
Agreement and Plan of Merger, dated as of March 17, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company
Merger Agreements
Sorrento Therapeutics, Inc.
2022
Sponsor Support Agreement, dated as of March 17, 2022, by and among Vickers Vantage Corp. I and each of the Persons set forth on Schedule I attached thereto
Sorrento Therapeutics, Inc.
2022
Company Stockholder Support Agreement, dated as of March 17, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Vickers Vantage Corp. I
Sorrento Therapeutics, Inc.
2022
Form of Amended and Restated Registration Rights Agreement
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
2022
Agreement and Plan of Merger, dated January 14, 2022, by and among Sorrento Therapeutics, Inc., VH Merger Sub I, Inc., VH Merger Sub II, LLC, Virex Health, Inc. and Fortis...
Merger Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2022
Amendment No. 1 to Amended and Restated Sales Agreement, dated as of December 23, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities,...
Sales Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2021
Amended and Restated Sales Agreement, dated as of December 3, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities, Inc., H.C. Wainwright &...
Sales Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2021
Earn-Out Agreement, dated June 1, 2021, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC
Sorrento Therapeutics, Inc.
Biotechnology
DE
2021
Contract, dated August 15, 2018, by and between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text...
Sorrento Therapeutics, Inc.
Biotechnology
2021
Loan Agreement, dated January 6, 2018, by and between Zhejiang ACEA Pharmaceutical Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text in...
Loan Agreements
Sorrento Therapeutics, Inc.
2021
Binding Term Sheet, dated as of February 24, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc
Term Sheets
Sorrento Therapeutics, Inc.
2021
Exclusive License Agreement, dated as of March 4, 2021, by and between Sorrento Therapeutics, Inc. and the Icahn School of Medicine at Mount Sinai
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2021
Amendment to Binding Term Sheet, dated as of April 20, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc
Term Sheets
Sorrento Therapeutics, Inc.
Biotechnology
2021
Sorrento Therapeutics, Inc. 2021 Cash-Settled Stock Appreciation Rights Plan
Stock Agreements
Sorrento Therapeutics, Inc.
2021
Sorrento Therapeutics, Inc. Stock Appreciation Rights Award Agreement
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2021
Agreement and Plan of Merger, dated April 2, 2021, by and among Sorrento Therapeutics, Inc., AT Merger Sub, Inc., ACEA Therapeutics, Inc. and Fortis Advisors LLC, as...
Merger Agreements
Sorrento Therapeutics, Inc.
2021
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
Biotechnology
2021
License Agreement, dated as of October 12, 2020, by and between Sorrento Therapeutics, Inc. and Personalized Stem Cells
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2021
Binding Term Sheet, dated as of October 14, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc
Term Sheets
Sorrento Therapeutics, Inc.
2021
Consent Under and Amendment No. 3 to Indenture and Letter of Credit, dated December 14, 2020, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank...
Credit Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Amendment No. 1 to Sales Agreement, dated as of December 4, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P./Alliance Global Partners
Sales Agreements
Sorrento Therapeutics, Inc.
2020
License Agreement, dated as of July 13, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc
License Agreements
Sorrento Therapeutics, Inc.
2020
Exclusive License Agreement, dated as of July 23, 2020, by and between Sorrento Therapeutics, Inc. and The Trustees of Columbia University in the City of New York
License Agreements
Sorrento Therapeutics, Inc.
2020
Patent and Know-How License Agreement, dated as of September 8, 2020, by and between Sorrento Therapeutics, Inc. and Mayo Foundation for Medical Education and Research
License Agreements
Sorrento Therapeutics, Inc.
2020
Change of Control Severance Agreement, dated as of November 5, 2020, by and between Sorrento Therapeutics, Inc. and Najjam Ashgar
Change of Control Agreements
Sorrento Therapeutics, Inc.
2020
Sorrento Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Sorrento Therapeutics, Inc.
2020
Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan
Bonus & Incentive Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
Performance Stock Option Award Agreement, dated as of August 7, 2020, by and between Sorrento Therapeutics, Inc. and Henry Ji, Ph.D
Bonus & Incentive Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2020
First Amendment to Exchange and Registration Rights Agreement, dated September 28, 2020, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC in its capacity as the...
Exchange Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
Agreement and Plan of Merger, dated August 20, 2020, by and among Sorrento Therapeutics, Inc., SP Merger Sub, Inc., SmartPharm Therapeutics, Inc. and John C. Thomas, Jr., as...
Merger Agreements
Sorrento Therapeutics, Inc.
2020
Outside Director Compensation Policy
Compensation Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2020
Omnibus Amendment No. 2 to Indenture and Letter of Credit, dated as of March 30, 2020, by and among Scilex Pharmaceuticals, Inc., Sorrento Therapeutics, Inc., U.S. Bank National...
Credit Agreements
Sorrento Therapeutics, Inc.
2020
Binding Term Sheet, dated as of March 31, 2020, by and between Sorrento Therapeutics, Inc., and Nanjing Hongjing Enterprise Management Consulting Co., Ltd
Consulting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
Sales Agreement, dated as of April 27, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P/Alliance Global Partners
Sales Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Common Stock Purchase Agreement, dated as of April 27, 2020, by and between Sorrento Therapeutics, Inc. and Arnaki Ltd
Stock Agreements
Sorrento Therapeutics, Inc.
2020
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
2020
Registration Rights Agreement, dated as of February 10, 2020, by and between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
IL
2020
Common Stock Purchase Agreement, dated as of February 10, 2020, by and between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
IL
2020
Form of Warrant, dated December 6, 2019, issued by Sorrento Therapeutics, Inc
Warrant Agreements
Sorrento Therapeutics, Inc.
2019
Amendment No. 2 to the Registration Rights Agreement, dated as of December 6, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2019
Amendment No. 1 to Agreement and Plan of Merger, dated as of August 7, 2019, by and between Scilex Holding Company and Fortis Advisors LLC, solely as the Equityholders...
Merger Agreements
Sorrento Therapeutics, Inc.
2019
Note Conversion Agreement, dated as of November 8, 2019, by and among Sorrento Therapeutics, Inc. and the holders of convertible notes issued by Sorrento Therapeutics, Inc. as is...
Note Agreements
Sorrento Therapeutics, Inc.
2019
Form of Securities Purchase Agreement, dated October 7, 2019, by and between the Company and the purchasers party thereto
Purchase Agreements
Sorrento Therapeutics, Inc.
2019
Equity Distribution Agreement, dated as of October 1, 2019, by and between Sorrento Therapeutics, Inc. and JMP Securities LLC
Equity Distribution Agreements
Sorrento Therapeutics, Inc.
2019
Omnibus Amendment No. 1 to Indenture and Letter of Credit, dated as of October 1, 2019, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank National...
Credit Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan
Bonus & Incentive Agreements
Sorrento Therapeutics, Inc.
2019
Underwriting Agreement, dated as of June 28, 2019, by and between Sorrento Therapeutics, Inc. and JMP Securities LLC, as representative of the underwriters named therein
Underwriting Agreements
Sorrento Therapeutics, Inc.
2019
Form of Series A Warrant
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Form of Series B Warrant
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Form of Series C Warrant
Warrant Agreements
Sorrento Therapeutics, Inc.
2019
Form of Warrant, dated May 3, 2019, issued by Sorrento Therapeutics, Inc
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Amendment No. 1 to the Registration Rights Agreement, dated as of May 3, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2019
Amendment No. 1 to Term Loan Agreement, dated as of May 3, 2019, by and among Sorrento Therapeutics, Inc., certain subsidiaries of Sorrento Therapeutics, Inc., as guarantors,...
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019
Exchange and Registration Rights Agreement, dated as of March 18, 2019, by and among Sorrento Therapeutics, Inc. and the stockholders and stock option holders of Semnur...
Exchange Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2019
Agreement and Plan of Merger, dated as of March 18, 2019, by and among Sorrento Therapeutics, Inc., Semnur Pharmaceuticals, Inc., Scilex Holding Company, Sigma Merger Sub, Inc....
Merger Agreements
Sorrento Therapeutics, Inc.
2019
First Amendment to Office Lease, dated October 19, 2018, between Sorrento Therapeutics, Inc. and HCP Life Science REIT, Inc
Lease Agreements
Sorrento Therapeutics, Inc.
2019
Lease Agreement, dated November 13, 2018, between Sorrento Therapeutics, Inc. and HCP Life Science Estates, Inc
Lease Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2019
Form of Warrant, dated November 7, 2018, issued by Sorrento Therapeutics, Inc
Warrant Agreements
Sorrento Therapeutics, Inc.
2018
Registration Rights Agreement, dated November 7, 2018, by and among Sorrento Therapeutics, Inc. and the parties identified on Schedule A thereto
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2018
Form of Purchase Agreement, dated as of September 7, 2018, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and the purchasers party thereto
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2018
Collateral Agreement, dated as of September 7, 2018, by and between Scilex Pharmaceuticals Inc. and U.S. Bank National Association, as trustee and collateral agent
Sorrento Therapeutics, Inc.
Biotechnology
DE
2018
Irrevocable Standby Letter of Credit, dated September 7, 2018, issued by Sorrento Therapeutics, Inc
Credit Agreements
Sorrento Therapeutics, Inc.
2018
Term Loan Agreement, dated November 7, 2018, by and among Sorrento Therapeutics, Inc., certain subsidiaries of Sorrento Therapeutics, Inc., the lenders party thereto and Oaktree...
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2018
Agreement and Consent, dated November 7, 2018, by and among Sorrento Therapeutics, Inc. and the Warrant Holders party thereto
Warrant Agreements
Sorrento Therapeutics, Inc.
2018
Amended and Restated 2009 Stock Incentive Plan, as amended
Bonus & Incentive Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2018
Form of Convertible Promissory Note issued to investors pursuant to the Securities Purchase Agreement, dated as of June 13, 2018, by and among Sorrento Therapeutics, Inc. and the...
Note Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2018
Form of Common Stock Purchase Warrant issued to investors pursuant to the Securities Purchase Agreement, dated as of June 13, 2018, by and among Sorrento Therapeutics, Inc. and...
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2018
Registration Rights Agreement, dated June 13, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2018
Offer Letter, dated March 15, 2018, by and between Sorrento Therapeutics, Inc. and Jiong Shao
Sorrento Therapeutics, Inc.
2018
Securities Purchase Agreement, dated as of March 26, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto
Purchase Agreements
Sorrento Therapeutics, Inc.
2018
Amendment No. 1 to Share Purchase Agreement, effective April 27, 2018, by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Dayspring Ventures Limited, as...
Share Agreements
Sorrento Therapeutics, Inc.
2018
Form of Convertible Promissory Note issued to investors pursuant to the Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc. and...
Note Agreements
Sorrento Therapeutics, Inc.
2017
Form of Common Stock Purchase Warrant issued to investors pursuant to the Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc....
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
Registration Rights Agreement, dated December 21, 2017, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto
Purchase Agreements
Sorrento Therapeutics, Inc.
2017
License and Transfer Agreement dated August 15, 2017 by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Celularity, Inc
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2017
Amendment No. 2 to Contribution Agreement, dated as of August 10, 2017, by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Celularity, Inc
Contribution Agreements
Sorrento Therapeutics, Inc.
2017
Seventh Amendment to Loan and Security Agreement, dated November 6, 2017, among Sorrento Therapeutics, Inc., certain of its domestic subsidiaries, and Hercules Capital, Inc
Loan Agreements
Sorrento Therapeutics, Inc.
2017
FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
CONSENT AND SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2017
AMENDMENT NO. 1 TO PROMISSORY NOTE
Note Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2017
AMENDMENT NO. 1 TO CONTRIBUTION AGREEMENT
Contribution Agreements
Sorrento Therapeutics, Inc.
2017
AMENDMENT NO. 2 TO PROMISSORY NOTE
Note Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2017
Fourth Amendment to Loan and Security Agreement, dated March 23, 2017, among Sorrento Therapeutics, Inc., certain of its domestic subsidiaries, and Hercules Capital, Inc
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
Amendment No. 3 to Stock Purchase Agreement, dated as of March 14, 2017, by and between TNK Therapeutics, Inc. and Richard P. Junghans, M.D., Ph.D., as the Stockholders...
Stock Agreements
Sorrento Therapeutics, Inc.
2017
Amended and Restated Employment Agreement between Sorrento Therapeutics, Inc. and Henry Ji, Ph.D. dated May 9, 2017
Employment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
SHARE PURCHASE AGREEMENT by and among TNKTherapeutics, Inc., VirttuBiologics Limited, TheShareholders of Virttu Biologics Limited, DayspringVentures Limited, as the...
Share Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2017
23,625,084 Shares SORRENTO THERAPEUTICS,INC. UNDERWRITING AGREEMENT(this “Agreement”)
Underwriting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2017
PROMISSORY NOTE
Note Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
BINDING TERM SHEET FOR VIRTTU BIOLOGICS ACQUISITION
Term Sheets
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2017
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2017
Amendment No. 2 to Stock PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2017
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2017
WARRANT AGREEMENT To PurchaseShares of the Common Stock of SORRENTO THERAPEUTICS, INC. Dated as of November 23, 2016 (the Effective Date)
Warrant Agreements
Sorrento Therapeutics, Inc.
2016
BINDING TERM SHEET FOR sCILEX PHARMACEUTICALS, INc. ACQUISITION AUGUST 2, 2016
Term Sheets
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
BINDING TERM SHEET August 15, 2016
Term Sheets
Sorrento Therapeutics, Inc.
2016
SORRENTO GATEWAY LEASE
Lease Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
Amendment No. 1 to MEmbership Interest PURCHASE AGREEMENT
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
2016
STOCK PURCHASE AGREEMENT by and among SORRENTO THERAPEUTICS, INC., SCILEX PHARMACEUTICALS INC., THE STOCKHOLDERS OF SCILEX PHARMACEUTICALS INC., AND SPISHAREHOLDERS...
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
[Signature Page Follows]
Sorrento Therapeutics, Inc.
2016
LICENSE AND COLLABORATION AGREEMENT BETWEEN LES LABORATOIRES SERVIER INSTITUT DE RECHERCHES INTERNATIONALES SERVIER AND SORRENTO THERAPEUTICS, INC.
Collaboration Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2016
SORRENTO THERAPEUTICS, INC. Employment Agreement
Employment Agreements
Sorrento Therapeutics, Inc.
2016
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Sorrento Therapeutics, Inc.
2016
OPTION AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 21, 2015 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
2015
MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among TNK Therapeutics, Inc., CARgenix Holdings LLC The Members of CARgenix Holdings LLC, Jaymin Patel, as the Members Representative...
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
RI
2015
STOCK PURCHASE AGREEMENT by and among TNK Therapeutics, Inc., BDL Products, Inc. The Stockholders of BDL Products, Inc., Richard Junghans, M.D., PH.D., as the Stockholders...
Stock Agreements
Sorrento Therapeutics, Inc.
2015
BINDING TERM SHEET FOR LICENSE BETWEEN CYTOLUMINA/FETOLUMINA AND TNK THERAPEUTICS
License Agreements
Sorrento Therapeutics, Inc.
2015
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2015
EXCLUSIVE LICENSE AGREEMENT
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2015
STOCK SALE AND PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2015
COMMON STOCK PURCHASE WARRANT SORRENTO THERAPEUTICS, INC.
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2015
FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sorrento Therapeutics, Inc.
2015
LEASE UNIVERSITY CENTER WEST HCP UNIVERSITY CENTER WEST LLC, a Delaware limited liability company, as Landlord, and SORRENTO THERAPEUTICS, INC., a Delaware corporation, as Tenant....
Lease Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2015
FIRSTAMENDMENT TO SUBSCRIPTION AND INVESTMENT AGREEMENT
Investment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2014
STOCKHOLDERS AGREEMENT dated as of December23, 2014 by and among CONKWEST, INC., SORRENTO THERAPEUTICS, INC., CAMBRIDGE EQUITIES, LP and THE PERSONS LISTEDON SCHEDULE A HERETO...
Sorrento Therapeutics, Inc.
2014
SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 22, 2014 1 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
DE
2014
SUBSCRIPTION AND INVESTMENT AGREEMENT
Investment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2014
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2014
Exclusive License and Development Agreement between Sorrento Therapeutics, Inc. and China Oncology Focus Limited 1
License Agreements
Sorrento Therapeutics, Inc.
2014
CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2014
AMENDMENT #7
Sorrento Therapeutics, Inc.
Biotechnology
2014
UNDERWRITING AGREEMENT between SORRENTOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters SORRENTO THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Underwriting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2014
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2014
SORRENTO THERAPEUTICS, INC. EMPLOYMENT AGREEMENT
Employment Agreements
Sorrento Therapeutics, Inc.
2014
AGREEMENT OF MERGER by and among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; CATALYST MERGER SUB, INC., a Delaware corporation; CONCORTIS BIOSYSTEMS, CORP., a Delaware...
Merger Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
SORRENTO THERAPEUTICS, INC. and COMPUTERSHARE TRUST COMPANY, N.A., Rights Agent Rights Agreement Dated as of November 7, 2013 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
DE
2013
UNDERWRITING AGREEMENT between SORRENTOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters SORRENTO THERAPEUTICS, INC. UNDERWRITING AGREEMENT
Underwriting Agreements
Sorrento Therapeutics, Inc.
2013
CONVERTIBLE PROMISSORY NOTE
Note Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; SPMERGER SUB, INC., a Delaware corporation; SHERRINGTON...
Merger Agreements
Sorrento Therapeutics, Inc.
2013
LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2013
REGISTRATION RIGHTSAGREEMENT BY AND AMONG SORRENTO THERAPEUTICS, INC. AND THE STOCKHOLDERS OF SHERRINGTON PHARMACEUTICALS,INC. Dated as of October 9, 2013 1 REGISTRATION RIGHTS...
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
AGREEMENT OF MERGER among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; STIMERGER SUB, INC., a Delaware corporation; IGDRASOL, INC., a Delaware corporation;...
Merger Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
EXCLUSIVE OPTION AGREEMENT by and between B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., an Israeli Company and SORRENTO THERAPEUTICS, INC., a Delaware (US) corporation EXCLUSIVE...
Sorrento Therapeutics, Inc.
2013
OPTION AGREEMENT Dated as of March 7, 2013 by and between SORRENTO THERAPEUTICS, INC. and IGDRASOL, INC. TABLE CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
ASSIGNMENT AGREEMENT by and between TIEN-LI LEE, M.D. AND JANE WU LEE, M.D., as individuals and SORRENTO THERAPEUTICS, INC., a Delaware (U.S.) corporation ASSIGNMENT AGREEMENT
Assignment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2013
ASSET PURCHASE AGREEMENT
Purchase Agreements
Sorrento Therapeutics, Inc.
2013
SERVICES AGREEMENT
Services Agreements
Sorrento Therapeutics, Inc.
2013
VOTING AGREEMENT
Voting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
SORRENTO THERAPEUTICS, INC. INDEPENDENT DIRECTOR COMPENSATION POLICY (as amended through December 12, 2012)
Compensation Agreements
Sorrento Therapeutics, Inc.
2013
STOCK OPTION CANCELLATION AGREEMENT AND OPTION AMENDMENT
Stock Agreements
Sorrento Therapeutics, Inc.
2013
STOCK OPTION CANCELLATION AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
LOAN AND SECURITY AGREEMENT
Loan Agreements
Sorrento Therapeutics, Inc.
2013
SORRENTO THERAPEUTICS, INC. EMPLOYMENT AGREEMENT
Employment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2012
SORRENTO THERAPEUTICS, INC. EMPLOYMENT AGREEMENT
Employment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2012
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
Sorrento Therapeutics, Inc.
2012
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
Sorrento Therapeutics, Inc.
2012
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Sorrento Therapeutics, Inc.
2012
AMENDMENT #6
Sorrento Therapeutics, Inc.
2012
FIRST AMENDMENT TO STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2012
SECOND AMENDMENT TO STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
2012
AMENDED AND RESTATED STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
2012
AMENDMENT #3
Sorrento Therapeutics, Inc.
Biotechnology
2012
AMENDMENT #4
Sorrento Therapeutics, Inc.
2012
AMENDMENT #5
Sorrento Therapeutics, Inc.
2012
STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2012
CONSULTING AGREEMENT
Consulting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2011
AMENDMENT #3
Sorrento Therapeutics, Inc.
2011
AMENDMENT #4
Sorrento Therapeutics, Inc.
2011
STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
2010
LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and SORRENTO THERAPEUTICS, INC., a Delaware corporation
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2010
CONSULTING AGREEMENT
Consulting Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2010
SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT.WEST, SUITE B SAN DIEGO, CA 92121, USA
Sorrento Therapeutics, Inc.
Biotechnology
2010
AMENDMENT #2
Sorrento Therapeutics, Inc.
2010
SORRENTO THERAPEUTICS, INC. 2009 EQUITY INCENTIVEPLAN Approved by the Board of Directors: February 5, 2009
Sorrento Therapeutics, Inc.
2010
AMENDMENT #2
Sorrento Therapeutics, Inc.
Biotechnology
2009
PLAN OF CONVERSION OF QuikByte Software, Inc., aColorado corporation, INTO QuikByte Software, Inc., a Delaware corporation
Sorrento Therapeutics, Inc.
2009
SORRENTO THERAPEUTICS, INC. TRANSFER FEE $25.00
Sorrento Therapeutics, Inc.
Biotechnology
2009
SORRENTO THERAPEUTICS, INC. INDEMNITY AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
DE
2009
SORRENTO THERAPEUTICS, INC. 2009 STOCK INCENTIVEPLAN
Stock Agreements
Sorrento Therapeutics, Inc.
2009
ESCROW AGREEMENT
Escrow Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2009
NONQUALIFIED STOCK OPTION AGREEMENT FOR QUIKBYTE SOFTWARE, INC. Agreement
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
FL
2009
STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
FL
2009
LOCK-UP AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
2009
ESCROW AGREEMENT
Escrow Agreements
Sorrento Therapeutics, Inc.
2009
QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137
Sorrento Therapeutics, Inc.
2009
QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137
Sorrento Therapeutics, Inc.
Biotechnology
2009
STANDARD MULTI-TENANTOFFICE LEASE - NET
Lease Agreements
Sorrento Therapeutics, Inc.
2009
FIRSTAMENDMENT TO LEASE
Lease Agreements
Sorrento Therapeutics, Inc.
2009
STOCK PURCHASE AGREEMENT
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2009
LIMITED LICENSE AGREEMENT
License Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2009
PATENT ASSIGNMENT AGREEMENT
Assignment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2009
NONQUALIFIED STOCK OPTION AGREEMENT FOR QUIKBYTE SOFTWARE, INC. Agreement
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
FL
2009
FIRST AMENDMENT TO MERGER AGREEMENT
Merger Agreements
Sorrento Therapeutics, Inc.
2009
MERGER AGREEMENT BY AND AMONG QUIKBYTE SOFTWARE, INC., SORRENTO THERAPEUTICS, INC., SORRENTO MERGER CORP., INC., STEPHEN ZANIBONI, as Stockholders Agent AND GLENN HALPRYN, as...
Merger Agreements
Sorrento Therapeutics, Inc.
2009
AGREEMENT
Sorrento Therapeutics, Inc.
2007
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Sorrento Therapeutics, Inc.
2007
Indenture and form of Note issued thereunder, dated as of September 7, 2018, by and among Scilex Pharmaceuticals Inc., as issuer, Sorrento Therapeutics, Inc., as parent guarantor,...
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2018
Amendment No. 1 to Securities Purchase Agreement, effective June 13, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers set forth on the signature pages thereto
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2018